Previous 10 | Next 10 |
2024-03-13 09:23:45 ET More on Bristol-Myers, Johnson & Johnson, etc. Johnson & Johnson (JNJ) Leerink Partners Global Biopharma Conference (Transcript) Bristol-Myers Squibb: Finally Trending Up Bristol-Myers Squibb: Turnaround Expected J&J submits...
2024-03-13 08:29:15 ET Read the full article on Seeking Alpha For further details see: KB Financial, BeiGene, Legend Biotech among premarket gainers' pack
2024-03-11 12:09:08 ET Legend Biotech Corporation (LEGN) Q4 2023 Earnings Conference March 11, 2024 08:00 AM ET Company Participants Jessie Yeung - Head of Investor Relations and Public Relations Ying Huang - Chief Executive Officer Lori Macomber - Chief Financia...
2024-03-11 07:01:47 ET More on Legend Biotech Legend Biotech: Solid Traction With Carvykti Rollout Legend Biotech FY 2023 Earnings Preview Legend Biotech stock rises after EU backs label expansion for multiple myeloma therapy Seeking Alpha’s Quant Rati...
Volcon Inc. (VLCN) is expected to report for Q4 2023 Tenaga Nasional Bhd ADR (TNABY) is expected to report for quarter end 2023-12-31 Hesai Group (HSAI) is expected to report for Q4 2023 Intrusion Inc. (INTZ) is expected to report $-0.14 for Q4 2023 Eliem Therapeutics Inc (ELYM) i...
CARVYKTI ® (ciltacabtagene autoleucel; cilta-cel) net trade sales of approximately $159 million and $500 million for the fourth quarter and full year 2023, respectively CHMP recommended CARVYKTI ® label expansion in earlier lines of treatment for adult patients with rela...
2024-03-10 13:08:00 ET More on ALX Oncology, Bicycle Therapeutics, etc. Immunocore Holdings plc (IMCR) Q4 2023 Earnings Call Transcript Kura Oncology, Inc. (KURA) Q4 2023 Earnings Call Transcript Kura Oncology, Inc. 2023 Q4 - Results - Earnings Call Presentation ...
2024-03-08 13:50:25 ET More on Legend Biotech Legend Biotech: Solid Traction With Carvykti Rollout Legend Biotech stock rises after EU backs label expansion for multiple myeloma therapy Johnson & Johnson wins EU backing to expand labeling for CAR-T therapy ...
2024-03-08 09:50:03 ET Major earnings expected before the bell on Monday include: Ballard Power Systems ( BLDP ) Eltek ( ELTK ) Endeavour Silver ( EXK ) Legend Biotech ( LEGN ) NewLake Capital Partners ( OTCQX:NLCP ) Overseas Shipholding Group (...
2024-03-07 10:30:02 ET RBC Capital analyst issues UNDERPERFORM recommendation for LEGN on March 7, 2024 10:00AM ET. The previous analyst recommendation was Underperform. LEGN was trading at $63.385 at issue of the analyst recommendation. The overall analyst consensus : B...
News, Short Squeeze, Breakout and More Instantly...
Legend Biotech Corporation Company Name:
LEGN Stock Symbol:
NASDAQ Market:
Legend Biotech Corporation Website:
SOMERSET, N.J., July 10, 2024 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, will host a conference call for investors at 8:00 am ET on Friday, August 9, 2024, to review second-quarter 2024 results. During the webcast and confe...
SOMERSET, N.J., July 02, 2024 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, announced today positive overall survival results from CARTITUDE-4, an ongoing, global randomized, open-label Phase 3 study evaluating the efficacy and sa...
2024-06-20 17:01:11 ET USA News Group News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – June 20,2024 – USA News Group News Commentary – The potential threat of cancer looms for everyone, but now new studies are revealing an increased number o...